Publisher
Springer Science and Business Media LLC
Reference7 articles.
1. Rechtman L, Brenner S, Wright M, Ritsick M, Rahman F, Han M, et al. Genetic risk scores may compound rather than solve the issue of prostate cancer overdiagnosis. Br J Cancer. 2022;9:1692–701.
2. Green HD, Merriel SWD, Oram RA, Ruth KS, Tyrrell J, Jones SE, et al. Applying a genetic risk score for prostate cancer to men with lower urinary tract symptoms in primary care to predict prostate cancer diagnosis: a cohort study in the UK Biobank. Br J Cancer. 2022;127:1534–9.
3. Conti DV, Darst BF, Moss LC, Saunders EJ, Sheng X, Chou A, et al. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. Nat Genet. 2021;53:413.
4. Klein RJ. ARTICLE Prostate cancer polygenic risk score and prediction of lethal prostate cancer. Christel Häggström [Internet]. [cited 2022 Oct 19];18:17. Available from: https://doi.org/10.1038/s41698-022-00266-8.
5. Merriel SWD, Pocock L, Gilbert E, Creavin S, Walter FM, Spencer A, et al. Systematic review and meta-analysis of the diagnostic accuracy of prostate-specific antigen (PSA) for the detection of prostate cancer in symptomatic patients. BMC Med. 2022;20:54.